|Bid||18.64 x 0|
|Ask||19.59 x 0|
|Day's range||18.93 - 19.18|
|52-week range||16.55 - 29.72|
|Beta (5Y monthly)||1.27|
|PE ratio (TTM)||9.46|
|Forward dividend & yield||1.17 (6.12%)|
|Ex-dividend date||27 May 2022|
|1y target est||N/A|
Evonik Industries AG ( ETR:EVK ) investors will be delighted, with the company turning in some strong numbers with its...
Evonik Industries ( ETR:EVK ) Third Quarter 2022 Results Key Financial Results Revenue: €4.88b (up 26% from 3Q 2021...
(Reuters) -German chemicals group Evonik Industries, which makes ingredients for Pfizer/BioNTech's COVID-19 vaccine, on Tuesday said it expected a rise in 2022 earnings despite a weakening economy, after third-quarter profit broadly met expectations. The company, which also makes ingredients for animal feed and diapers, sees full-year adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) between 2.5 billion to 2.6 billion euros, above the 2021 figure of 2.38 billion euros. She noted that raw material and logistic costs have started to fall as supply challenges eased and that maintaining attractive price levels in a slowing environment would be the next proof of Evonik's specialty portfolio.